Belite Bio, Inc
Price
FilingsNewest: 6-K, Report of a foreign issuerSep 8 →InsidersNo open-market buys. 5 insiders sold $40.5M, 154 of 167 sales on a 10b5-1 plan.→HoldersDarwin Global $456.6MParadigm Biocapital $189.8MRTW Investments $110.2M→
From the filings
Figures
- Net income
- −$77.6Mlast 12 months
- Operating cash flow
- −$37.0Mlast 12 months
- Cash and equivalents
- $352.9Mat the last balance sheet